Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Argent Biopharma ( (AU:RGT) ) has shared an announcement.
Argent Biopharma Limited has announced the quotation of 5,000,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code RGT, effective January 16, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and provide additional capital for its operational and strategic initiatives.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. The company is known for its commitment to advancing medical treatments and is actively involved in the healthcare market.
YTD Price Performance: 27.50%
Average Trading Volume: 163,509
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.27M
Learn more about RGT stock on TipRanks’ Stock Analysis page.
